P. Johnson

发表

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.

A. Pettitt, C. Crawley, J. Snowden, 2010, Blood.

Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.

N. Potter, C. Craddock, R. Hills, 2019, Blood.

A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients

M. Copland, E. Allan, A. Parker, 2005, Bone Marrow Transplantation.

Poor performance of galactomannan and mannan sandwich enzyme‐linked immunosorbent assays in the diagnosis of invasive fungal infection

M. Copland, T. Holyoake, E. Allan, 2005, British journal of haematology.

Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.

N. Russell, G. Cook, A. Pagliuca, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.

J. Satsangi, J. Gribben, S. Vermeire, 2015, JAMA.

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.

B. Leber, T. A. Lister, J. Fitzgibbon, 2008, Blood.

THE ROLE OF GRANULOCYTE‐ AND GRANULOCYTE‐MACROPHAGE‐COLONY‐STIMULATING FACTORS IN THE TREATMENT OF ACUTE MYELOID LEUKAEMIA

J. A. Liu Yin, Peter R. E. Johnson, P. Johnson, 1997, British journal of haematology.

UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy

E. Tholouli, N. Russell, R. Malladi, 2018, Journal of clinical apheresis.

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

G. Morgan, W. Gregory, M. Drayson, 2012, Haematologica.

Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐ and lenalidomide‐containing regimens

A. Mathur, P. Roddie, N. Storrar, 2019, British journal of haematology.

Spontaneous clinical regression in chronic lymphocytic leukaemia

D. Catovsky, P. Shepherd, I. Ribeiro, 2002, British journal of haematology.

The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study

C. Fegan, J. Byrne, J. Snowden, 2006, British journal of haematology.

Effectiveness of Clofarabine in Elderly AML Patients with Adverse Cytogenetics Unfit for Intensive Chemotherapy.

M. Baccarani, R. Hills, N. Russell, 2006 .

M. Dimopoulos, P. Richardson, P. Moreau, 2020, Leukemia & lymphoma.

platelet disorder with propensity to myeloid malignancy Five new pedigrees with inherited RUNX1 mutations causing familial

B. Leber, T. A. Lister, M. Poon, 2013 .

Short communication Trisomy 14 in myeloid malignancies: report of two cases and review of the literature

Y. Horton, P. Johnson, 2001 .

A phase II study (Biov-121) of clofarabine monotherapy first line in patients aged 65 years or older with acute myeloid leukemia for whom standard intensive chemotherapy is not considered suitable.

M. Baccarani, R. Hills, N. Russell, 2006 .

From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol.

M. Fallon, S. Fleetwood-Walker, Peter R. E. Johnson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.